Zobrazeno 1 - 10
of 295
pro vyhledávání: '"Steve, Ryder"'
Autor:
Mohamed N. M. T. Al Khayat, Nigel Armstrong, Jeremy Howick, Susan O’Meara, Pawel Posadzki, Steve Ryder, Charlotte Ahmadu, Stefan R. A. Konings, Maarten J. Postma, Steven Duffy, Robert F. Wolff, Antoinette D. I. van Asselt
Publikováno v:
PharmacoEconomics. 41:353-361
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bbc3b1810a8a5b9339305fce4e42c87
https://doi.org/10.1007/s40273-023-01247-w
https://doi.org/10.1007/s40273-023-01247-w
Autor:
Nigel Armstrong, Nasuh Büyükkaramikli, Hannah Penton, Rob Riemsma, Pim Wetzelaer, Vanesa Huertas Carrera, Stephanie Swift, Thea Drachen, Heike Raatz, Steve Ryder, Dhwani Shah, Titas Buksnys, Gill Worthy, Steven Duffy, Maiwenn Al, Jos Kleijnen
Publikováno v:
Health Technology Assessment, Vol 24, Iss 51 (2020)
Background: There have been no licensed treatment options in the UK for treating thrombocytopenia in people with chronic liver disease requiring surgery. Established management largely involves platelet transfusion prior to the procedure or as rescue
Externí odkaz:
https://doaj.org/article/c59e5b6200d84298a2c9f75acd4ef74a
Autor:
Stefan Rennick-Egglestone, Mohsan Subhani, Holly Knight, Katy A Jones, Clare Hutton, Tracey Jackson, Matthew Hutton, Andrew Wragg, Joanne R Morling, Kirsty Sprange, Steve Ryder
BACKGROUND Mortality from alcohol-related liver disease has risen significantly for three decades. Transient elastography (TE) is a non-invasive test providing a numerical marker of liver disease. Preliminary evidence suggests that receiving TE can r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fca51174bc9886a365f99201785792b
https://doi.org/10.2196/preprints.47109
https://doi.org/10.2196/preprints.47109
Autor:
Steven Duffy, Manuela A. Joore, Nigel Armstrong, Annette Chalker, Sabine Grimm, Robert Wolff, Isabel Syndikus, Mickaël Hiligsmann, Willem J.A. Witlox, Jos Kleijnen, Charlotte Ahmadu, Ben F. M. Wijnen, Steve Ryder
Publikováno v:
Pharmacoeconomics. 40(5):509-518
The National Institute for Health and Care Excellence (NICE) invited the manufacturer (Kyowa Kirin) of mogamulizumab (Poteligeo(R)), as part of the single technology appraisal process, to submit evidence for its clinical and cost-effectiveness for pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1ab53ca166964105141105c17b0b0b
https://doi.org/10.1007/s40273-021-01098-3
https://doi.org/10.1007/s40273-021-01098-3
Autor:
Ben Wijnen, Willem Witlox, Robert Wolff, Debra Fayter, Bram Ramaekers, Thomas Otten, Steve Ryder, Pawel Posadzki, Gill Worthy, Lisa Stirk, Nigel Armstrong, Jos Kleijnen, Manuela Joore
Publikováno v:
PharmacoEconomics.
Fenfluramine, tradename Fintepla ®, was appraised within the National Institute for Health and Care Excellence (NICE) single technology appraisal (STA) process as Technology Appraisal 808. Within the STA process, the company (Zogenix International)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ae66be15903964cba56685d72cb004
https://pubmed.ncbi.nlm.nih.gov/36301414
https://pubmed.ncbi.nlm.nih.gov/36301414
Autor:
Titas Buksnys, Nigel Armstrong, Steve Ryder, Elena Castro, Kathleen M. Fox, Janine Ross, Carol A. Forbes, R.G.W. Quek
Publikováno v:
Future Oncology. 17:853-864
Background: Ongoing clinical trials are investigating poly(ADP-ribose) polymerase (PARP) inhibitors to target the DNA damage repair (DDR) pathway in prostate cancer. DDR mutation screening will guide treatment strategy and assess eligibility for clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22a2579d34b111a63202b1e07cefdfc1
https://doi.org/10.2217/fon-2020-0569
https://doi.org/10.2217/fon-2020-0569
Autor:
Rob Riemsma, Isaac Corro Ramos, Richard Birnie, Nasuh Büyükkaramikli, Nigel Armstrong, Steve Ryder, Steven Duffy, Gill Worthy, Maiwenn Al, Johan Severens, Jos Kleijnen
Publikováno v:
Health Technology Assessment, Vol 20, Iss 17 (2016)
Background: In recent years, meters for continuous monitoring of interstitial fluid glucose have been introduced to help people with type 1 diabetes mellitus (T1DM) to achieve better control of their disease. Objective: The objective of this project
Externí odkaz:
https://doaj.org/article/cef3222f3338437f8d6576a53d7d4d0a
Autor:
Marie Westwood, Willem J.A. Witlox, Debra Fayter, Ben F. M. Wijnen, Kate Misso, Steve Ryder, Titas Buksnys, Nigel Armstrong, Gill Worthy, Bram Ramaekers, Manuela A. Joore, Sabine Grimm, Jos Kleijnen
Publikováno v:
Pharmacoeconomics. 38(10):1043-1053
GW Research Ltd. provided two separate, but similar, submissions to the National Institute for Health and Care Excellence (NICE) on the clinical and cost-effectiveness of cannabidiol (CBD) 10 mg/kg/day, trade name Epidyolex(R), for the adjunctive tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d167585eeb19c3050f3d481cb607441
https://doi.org/10.1007/s40273-020-00932-4
https://doi.org/10.1007/s40273-020-00932-4